Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

CervoMed (CRVO) Revenue (2023 - 2025)

CervoMed (CRVO) has disclosed Revenue for 8 consecutive years, with $8726.0 as the latest value for Q4 2025.

  • Quarterly Revenue fell 99.6% to $8726.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.0 million through Dec 2025, down 58.86% year-over-year, with the annual reading at $4.0 million for FY2025, 58.86% down from the prior year.
  • Revenue hit $8726.0 in Q4 2025 for CervoMed, down from $322569.0 in the prior quarter.
  • In the past five years, Revenue ranged from a high of $3.3 million in Q2 2024 to a low of $8726.0 in Q4 2025.
  • Historically, Revenue has averaged $1.7 million across 3 years, with a median of $1.8 million in 2025.
  • Biggest five-year swings in Revenue: skyrocketed 91.23% in 2024 and later tumbled 99.6% in 2025.
  • Year by year, Revenue stood at $2.5 million in 2023, then decreased by 13.19% to $2.2 million in 2024, then crashed by 99.6% to $8726.0 in 2025.
  • Business Quant data shows Revenue for CRVO at $8726.0 in Q4 2025, $322569.0 in Q3 2025, and $1.8 million in Q2 2025.